Loading organizations...
Galileo Partners, also operating as Galileo Global Advisors within the broader Galileo Global Group, is a globally focused independent strategic advisory firm that facilitates cross-border transactions for small and mid-sized private market assets. The organization operates through a network of allied entities to provide investment banking, brokerage, and management consulting services to both public and private sector institutions. Their advisory engagements primarily focus on specialized industries, including the biopharmaceutical, medical device, and broader health technology sectors. The firm's leadership team and key division heads include financial executives Georges Ugeux, Francois Pages of Galileo Global Securities, and Charles-André Brouwers of Galileo Life Sciences. Operating without raising external institutional funding, the firm generates its revenue entirely through client advisory fees and brokerage commissions on completed corporate transactions. The organization was originally founded in 2003 by Georges Ugeux.
Galileo Partners has 6 tracked investments across 4 companies. The latest tracked deal is $30.0M Series C in Classy in November 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2016 | Classy | $30.0M Series C | Brian Hersman | Bullpen Capital, Mithril Capital Management, Salesforce Ventures |
| Aug 1, 2015 | Scality | $57.0M Series D | Doug Carlisle | David Ibnale, Canaan Partners, Iris Capital, Operator Collective, Cynthia Ringo, Eric VER Ploeg, Frederic LE Brun, Hiroshi Fujiwara, Matthieu Baret, Renaud Poulard |
| Jul 1, 2013 | Scality | $22.0M Series C | Iris Capital, Doug Carlisle | David Ibnale, Canaan Partners, Operator Collective, Cynthia Ringo, Eric VER Ploeg, FSN PME, Idinvest Partners, Omnes Capital |
| Jun 8, 2011 | VirtuOz | $7.0M Other Equity | — | Inventures Group, Mohr Davidow Ventures |
| Apr 1, 2010 | Talend | $8.0M Series D | — | Balderton Capital, AGF Private Equity |
| Jan 28, 2009 | VirtuOz | $11.4M Series B | Mohr Davidow Ventures | Eric Hahn |